New Chief Scientific Adviser Appointed To Executive

The Executive Office has announced the appointment of Professor Helen McCarthy as the Executive's new Chief Scientific and Technology Adviser.

Professor McCarthy's key responsibilities include co-ordinating a regional strategy on science and technology. She will also chair the newly formed NI Science & Technology Advisory Network.

First Minister Michelle O’Neill said: "We have world-leading technology businesses here in key sectors. The appointment of Professor McCarthy is an important step to assist the Executive in maximising opportunities. We want to ensure we grow the sector we have, and provide possibilities for emerging sectors which will lead to the creation of higher value jobs, real economic growth and positive social development."

Deputy First Minister Emma Little-Pengelly added: "This appointment will help us capitalise on our science and technology capabilities, driving forward our vision for growing our economy in key areas such as cyber security, artificial intelligence, diagnostics, advanced engineering and low carbon technologies, among others. It will help ensure government, academia and business work together to further economic prosperity and sustainable growth."

Professor McCarthy is currently Chair of Nanomedicine in the School of Pharmacy at Queen’s University. After 10 years of research on novel delivery systems for vaccines Helen spun out her technology into pHion Therapeutics. She was CEO for 6 years and secured almost £10million in funding from Innovate UK. During this time, she won INVENT NI and the All-Ireland Seedcorn Awards.

Welcoming the appointment, QUB President and Vice Chancellor Sir Ian Greer said: "We are delighted that Professor McCarthy has been offered such a prestigious position.

"Professor McCarthy has been a huge asset to Queen's in her role as Associate Dean of the Graduate School, as well as leading the Postgraduate Research Solutions Centre. More recently, Helen has been Associate Pro-Vice-Chancellor of Academic Business Development working on a range of special projects at a leadership level. I have no doubt that her wealth of experience in both industry and research will be invaluable to her role as Chief Scientific and Technology Adviser to the Northern Ireland Executive, while continuing her role as a Professor here at Queen's on a part-time basis."

This is the first time Northern Ireland has had an Executive Chief Scientific and Technology Adviser. The role will focus on advising on matters relating to the extensive science and technology network across government and the wider public sector.